TY - JOUR T1 - Reduction of O-Linked <em>N</em>-Acetylglucosamine-Modified Assembly Protein-3 in Alzheimer’s Disease JF - The Journal of Neuroscience JO - J. Neurosci. SP - 2399 LP - 2411 DO - 10.1523/JNEUROSCI.18-07-02399.1998 VL - 18 IS - 7 AU - Pamela J. Yao AU - Paul D. Coleman Y1 - 1998/04/01 UR - http://www.jneurosci.org/content/18/7/2399.abstract N2 - Abnormal protein processing and modification is associated with Alzheimer’s disease (AD) pathology. The role of phosphorylation in AD has been studied extensively because the presumed abnormal phosphorylation of tau protein is believed to play a role in the formation of paired helical filaments. Glycosylation with O-linkedN-acetylglucosamine (O-GlcNAc) to serine and threonine residues is a dynamic protein modification of intracellular proteins, and it shares similar features with protein phosphorylation. In this study, O-GlcNAc glycosylation of proteins from autopsied human brains with confirmed AD and non-AD age-matched controls was examined.O-GlcNAcylation was demonstrated by labeling protein extracts with [3H]galactose in the presence of galactosyltransferase and subsequent analyses of saccharide–protein linkage and saccharide structure. The number ofO-GlcNAc-containing proteins and the overallO-GlcNAc level do not appear to be different between AD and control brain tissues. The only significant change observed is a marked reduction of O-GlcNAcylated clathrin assembly protein-3 (AP-3) in AD. The reduction is more evident in brain neocortical regions, and there appears to be a negative correlation between O-glycosylated AP-3 and the density of neurofibrillary tangles. These data suggest a possible association between the O-glycosylated AP-3 and AD pathology. ER -